PEOPLE ON THE MOVE
Alexza Pharmaceuticals
Californian drugmaker Alexza Pharmaceuticals, which concentrates on unmet needs in the CNS space, has announced it has eliminated its Chief Operations Officer position.
Robert Lippe will leave the company June 12 with four months’ severance pay of $315,717. Alexza said his departure is part of a “revised commercial production strategy and his resignation was not the result of any disagreement with the company on any matter relating to its operations, policies or practices, or regarding the general direction of the company.”